Nifty

:

15097.35

Sensex

:

51039.31

115.35 (0.77%)
387.85 (0.77%)

Login

Nifty
Sensex

:
:

15097.35
51039.31

115.35 (0.77%)
387.85 (0.77%)

Sun Pharma Advanced Research Company Ltd.

Pharmaceuticals & Drugs - Global

Rating :

41/99

BSE: 532872 | NSE: SPARC

Watchlist

NSE BSE

168.30

25-Feb-2021

Open
High
Low
Previous Close

170.00
170.40
167.50
169.75

Volume
Traded Value (lacs)
52 Week High
52 Week Low

759964
1284.03
209.70
81.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,443.02
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,510.90
N/A
-97.78

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.79
-13.79
-0.62

EBITDA CAGR (%)

10 Years
5 Years
3 Years

46.89
37.45
5.03

PAT CAGR (%)

10 Years
5 Years
3 Years

43.39
34.88
16.61

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-35.06
-35.06
-35.06

EV:EBITDA (Average)

8 Years
5 Years
3 Years

0.93
-38.72
-28.69

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 21.81 19.60 11.28% 17.64 17.19 2.62% 185.45 17.32 970.73% 22.71 84.83 -73.23%
Expenses 84.77 73.31 15.63% 100.01 80.11 24.84% 124.67 112.34 10.98% 121.07 96.75 25.14%
EBITDA -62.96 -53.71 - -82.37 -62.92 - 60.78 -95.02 - -98.36 -11.92 -
EBIDTM -288.67% -274.03% -466.95% -366.03% 32.77% -548.61% -0.29% -0.29%
Other Income 1.60 0.71 125.35% 2.82 2.26 24.78% 0.66 3.67 -82.02% 3.12 4.43 -29.57%
Interest 3.50 0.26 1,246.15% 1.16 0.25 364.00% 1.97 0.59 233.90% 1.57 0.04 3,825.00%
Depreciation 2.76 2.25 22.67% 2.78 2.25 23.56% 2.78 2.25 23.56% 2.73 1.82 50.00%
PBT -67.62 -55.51 - -83.49 -63.16 - 56.69 -94.19 - -99.54 -9.35 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -67.62 -55.51 - -83.49 -63.16 - 56.69 -94.19 - -99.54 -9.35 -
PATM -310.04% -283.21% -473.30% -367.42% 30.57% -543.82% 2.87% 2.87%
EPS -2.58 -2.12 - -3.19 -2.41 - 2.16 -3.60 - -3.80 -0.36 -

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 247.61 76.81 182.87 78.26 181.02 161.28 155.74 167.03 87.28 28.98 58.35 Net Sales Growth 78.21% -58.00% 133.67% -56.77% 12.24% 3.56% -6.76% 91.37% 201.17% -50.33% Cost Of Goods Sold 515.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit -267.51 76.81 182.87 78.26 181.02 161.28 155.74 167.03 87.28 28.98 58.35 GP Margin -108.04% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 430.52 386.83 334.16 320.87 303.72 224.48 190.83 133.54 104.04 98.92 64.98 Power & Fuel Cost - 5.14 5.08 4.92 4.67 4.49 4.78 3.95 3.85 3.35 2.76 % Of Sales - 6.69% 2.78% 6.29% 2.58% 2.78% 3.07% 2.36% 4.41% 11.56% 4.73% Employee Cost - 93.09 81.06 100.92 84.30 56.60 45.79 40.40 36.55 30.43 25.67 % Of Sales - 121.20% 44.33% 128.95% 46.57% 35.09% 29.40% 24.19% 41.88% 105.00% 43.99% Manufacturing Exp. - 30.47 17.81 31.79 33.41 26.42 17.96 16.19 15.84 12.99 13.07 % Of Sales - 39.67% 9.74% 40.62% 18.46% 16.38% 11.53% 9.69% 18.15% 44.82% 22.40% General & Admin Exp. - 251.32 221.40 181.18 176.28 131.88 119.37 71.71 46.26 51.31 22.72 % Of Sales - 327.20% 121.07% 231.51% 97.38% 81.77% 76.65% 42.93% 53.00% 177.05% 38.94% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 6.81 8.80 2.05 5.06 5.08 2.94 1.29 1.54 0.85 0.00 % Of Sales - 8.87% 4.81% 2.62% 2.80% 3.15% 1.89% 0.77% 1.76% 2.93% 1.30% EBITDA -182.91 -310.02 -151.29 -242.61 -122.70 -63.20 -35.09 33.49 -16.76 -69.94 -6.63 EBITDA Margin -73.87% -403.62% -82.73% -310.01% -67.78% -39.19% -22.53% 20.05% -19.20% -241.34% -11.36% Other Income 8.20 9.76 13.51 4.94 13.72 2.94 3.03 10.00 1.62 1.15 1.24 Interest 8.20 2.67 0.09 0.12 1.82 2.16 0.22 5.60 3.95 0.27 0.13 Depreciation 11.05 9.48 7.55 8.18 8.24 7.58 7.24 3.57 3.40 3.16 2.99 PBT -193.96 -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 -22.49 -72.23 -8.51 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.00 0.00 0.00 -0.01 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.66% 0.00% 0.00% 0.12% PAT -193.96 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 -22.49 -72.23 -8.50 PAT before Minority Interest -193.96 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 -22.49 -72.23 -8.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -78.33% -406.72% -79.53% -251.73% -65.76% -43.40% -25.38% 18.15% -25.77% -249.24% -14.57% PAT Growth 0.00% - - - - - - - - - EPS -7.40 -11.92 -5.55 -7.52 -4.54 -2.67 -1.51 1.16 -0.86 -2.76 -0.32

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds -18.64 296.24 184.72 158.16 31.80 99.80 139.30 108.43 -66.61 5.62 Share Capital 26.21 26.21 25.09 24.69 23.67 23.67 23.67 23.66 20.71 20.71 Total Reserves -44.84 270.03 67.96 133.47 6.23 76.13 115.63 84.77 -87.32 -15.09 Non-Current Liabilities 55.85 7.20 11.98 10.36 10.02 9.72 9.45 6.32 7.23 7.48 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 6.38 1.09 1.64 2.18 2.73 3.27 3.82 4.36 5.74 6.30 Long Term Provisions 10.23 6.11 10.34 8.18 7.30 6.37 5.48 1.73 1.24 1.06 Current Liabilities 235.36 95.04 116.11 108.03 124.84 37.15 38.79 94.24 145.03 64.66 Trade Payables 158.84 82.92 102.48 94.45 58.15 27.01 29.75 12.79 16.23 10.31 Other Current Liabilities 9.78 7.66 9.42 9.81 12.09 8.98 7.58 3.79 66.06 53.17 Short Term Borrowings 61.42 0.00 0.10 0.41 52.48 0.40 0.82 75.97 61.94 0.29 Short Term Provisions 5.31 4.46 4.10 3.35 2.12 0.77 0.64 1.69 0.79 0.89 Total Liabilities 272.57 398.48 312.81 276.55 166.66 146.67 187.54 208.99 85.65 77.76 Net Block 103.86 57.56 51.74 69.16 69.96 66.79 64.49 65.55 63.93 62.93 Gross Block 135.50 80.22 67.17 77.28 106.82 96.38 86.98 84.57 79.58 75.45 Accumulated Depreciation 31.64 22.66 15.44 8.12 36.86 29.58 22.49 19.02 15.65 12.52 Non Current Assets 205.38 141.09 137.59 118.27 98.88 83.46 76.87 69.14 66.97 65.27 Capital Work in Progress 32.07 24.13 3.27 1.47 0.87 0.02 0.76 0.16 1.14 1.26 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 69.24 59.29 82.48 47.45 27.99 16.55 11.50 3.30 1.69 0.89 Other Non Current Assets 0.20 0.12 0.10 0.19 0.07 0.09 0.11 0.13 0.21 0.19 Current Assets 67.19 257.38 175.22 158.28 66.59 62.93 110.12 139.01 18.24 12.50 Current Investments 8.49 210.58 107.57 9.65 0.00 0.00 6.50 96.91 0.00 2.47 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 16.05 10.17 17.56 38.90 9.16 19.89 28.00 25.06 4.26 2.63 Cash & Bank 0.46 0.68 1.32 70.31 12.75 17.34 6.56 6.72 6.50 5.15 Other Current Assets 42.19 2.57 2.04 1.95 44.69 25.70 69.06 10.33 7.48 2.25 Short Term Loans & Adv. 39.33 33.39 46.73 37.48 43.35 24.27 63.34 9.69 7.15 2.02 Net Current Assets -168.17 162.34 59.11 50.25 -58.24 25.79 71.33 44.77 -126.79 -52.16 Total Assets 272.57 398.47 312.81 276.55 166.65 146.67 187.55 208.99 85.64 77.77

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -210.81 -171.91 -182.77 -128.04 -44.21 -41.17 36.90 -95.34 -69.45 2.29 PBT -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 -22.49 -72.23 -8.51 Adjustment 9.44 -21.77 3.82 -1.14 9.25 4.73 0.90 5.71 2.87 2.70 Changes in Working Capital 102.02 -0.17 20.48 12.86 30.41 -3.74 9.80 -77.91 0.70 8.14 Cash after chg. in Working capital -200.95 -167.38 -221.68 -107.32 -30.34 -38.53 45.03 -94.69 -68.66 2.33 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -9.86 -4.54 -10.08 -20.72 -13.87 -2.64 -8.13 -0.65 -0.79 -0.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 48.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 155.35 -102.19 -104.62 -6.61 -13.08 53.00 43.59 -99.31 -2.42 -7.64 Net Fixed Assets -63.22 -33.91 8.31 28.94 -11.29 -8.66 -3.01 -4.01 -4.01 -4.15 Net Investments 202.09 -103.01 -97.92 -9.65 0.00 6.50 90.41 -96.91 2.47 -2.47 Others 16.48 34.73 -15.01 -25.90 -1.79 55.16 -43.81 1.61 -0.88 -1.02 Cash from Financing Activity 55.46 274.25 224.01 194.25 50.55 -1.26 -80.84 194.38 72.10 4.41 Net Cash Inflow / Outflow 0.00 0.15 -63.38 59.60 -6.74 10.57 -0.35 -0.27 0.23 -0.93 Opening Cash & Equivalents 0.35 0.20 63.58 4.00 10.63 0.01 0.33 0.57 0.34 1.27 Closing Cash & Equivalent 0.35 0.35 0.20 63.58 4.00 10.63 0.01 0.33 0.57 0.34

Financial Ratios

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) -0.71 11.30 3.71 6.41 1.21 4.18 5.82 4.52 -3.16 0.27 ROA -93.11% -40.89% -66.85% -53.72% -44.68% -23.65% 15.29% -15.27% -88.40% -11.33% ROE -225.08% -74.72% -156.84% -127.40% -109.16% -33.17% 24.62% -110.94% 0.00% -86.09% ROCE -178.22% -59.95% -113.05% -94.66% -71.37% -31.74% 24.02% -19.55% -1066.48% -58.87% Fixed Asset Turnover 0.71 2.48 1.08 1.97 1.59 1.70 1.95 1.06 0.37 0.80 Receivable days 62.28 27.67 131.66 48.45 32.87 56.11 57.97 61.31 43.42 9.80 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 316.55 300.15 244.72 211.37 163.03 136.14 120.80 88.65 96.96 87.32 Cash Conversion Cycle -254.27 -272.48 -113.05 -162.92 -130.16 -80.03 -62.83 -27.34 -53.54 -77.52 Total Debt/Equity -3.67 0.01 0.02 0.02 1.94 0.04 0.04 0.75 -1.02 1.17 Interest Cover -115.79 -1547.78 -1596.71 -64.41 -31.45 -180.04 7.13 -4.69 -261.76 -65.47

Top Investors:

sun pharmaceutical industries key employees benefit trust

lakshdeep investments & finance (p) ltd

Annual Reports:

News Update:

Sun Pharma initiates Phase 2 clinical trial for SCD-044 in patients
5th Jan 2021, 09:12 AM

The study will enroll approximately 240 subjects and top line results are expected in 2022
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback